Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carbapenemase-producing Enterobacteriaceae Infection”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableUnknownNCT05850871
What this trial is testing

Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Qianfoshan Hospital 427
Not applicableStudy completedNCT01764490
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study

Who this might be right for
Clinically Significant Bacteremia
JESUS RODRIGUEZ BAÑO 1,344
Not applicableStudy completedNCT02420366
What this trial is testing

Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

Who this might be right for
Urinary Tract Infection, ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+2 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 257
Not applicableUnknownNCT04995965
What this trial is testing

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg

Who this might be right for
Nfections, Enterobacterial
University Hospital, Strasbourg, France 274
Not applicableStudy completedNCT03924934
What this trial is testing

Community-associated Highly-Resistant Enterobacterales

Who this might be right for
Enterobacteriaceae InfectionsCommunity-Acquired InfectionsHealthcare Associated Infection+1 more
University of North Carolina, Chapel Hill 2,172
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Large-scale testing (Phase 3)Temporarily pausedNCT03802461
What this trial is testing

Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization

Who this might be right for
Infection
Susy Hota 40
Not applicableLooking for participantsNCT06258551
What this trial is testing

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Who this might be right for
Antimicrobial Drug ResistanceAntibiotic Resistant InfectionClostridium Difficile+5 more
The Methodist Hospital Research Institute 1,000
Large-scale testing (Phase 3)Ended earlyNCT05258851
What this trial is testing

Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
King Faisal Specialist Hospital & Research Center 29
Testing effectiveness (Phase 2)WithdrawnNCT03643887
What this trial is testing

Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

Who this might be right for
Clostridium Difficile Infection
University of Wisconsin, Madison
Early research (Phase 1)Ended earlyNCT02922816
What this trial is testing

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Who this might be right for
Infection Due to Resistant Organism
Emory University 11
Large-scale testing (Phase 3)Looking for participantsNCT07089186
What this trial is testing

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd. 80
Large-scale testing (Phase 3)Ended earlyNCT04876430
What this trial is testing

Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream Infection
Hospital de Clinicas de Porto Alegre 13
Large-scale testing (Phase 3)UnknownNCT04746222
What this trial is testing

Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Tan Tock Seng Hospital 108
Not applicableUnknownNCT03967301
What this trial is testing

Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics

Who this might be right for
ProbioticsEnterobacteriaceae Infections
Hospital Italiano de Buenos Aires 228
Not applicableStudy completedNCT03646227
What this trial is testing

Multi-Drug Resistant Organism Network

Who this might be right for
Infections Resistant to Multiple DrugsBacterial Infections
Duke University 6,496
Not applicableLooking for participantsNCT07086391
What this trial is testing

Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionPneumonia - Bacterial
Fujian Medical University Union Hospital 144
Not applicableStudy completedNCT05985057
What this trial is testing

A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUs

Who this might be right for
Carbapenem Resistant Enterobacteriaceae InfectionArtificial IntelligenceIntensive Care Unit
Kocaeli University 289
Not applicableEnded earlyNCT05210387
What this trial is testing

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream InfectionSevere Infection+7 more
Hospital Moinhos de Vento 107
Not applicableStudy completedNCT02852902
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

Who this might be right for
Clinically Significant BacteremiaOrgan TransplantationInfection+6 more
Spanish Network for Research in Infectious Diseases 820
Load More Results